CORY WILHITE: Open Payments
NPI 1316215064 · PORTERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 80 payments from 17 companies in 2025. Trend: 2023 $1,735 · 2024 $1,480 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $212 |
| Lilly USA, LLC | 11 | $192 |
| GlaxoSmithKline, LLC. | 8 | $165 |
| Novo Nordisk Inc | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Amgen Inc. | 4 | $74 |
| PFIZER INC. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
Products named: MOUNJARO, TRELEGY ELLIPTA, UBRELVY, QULIPTA, TRINTELLIX, BREZTRI, OTEZLA, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
